Suppr超能文献

一项关于意大利初级保健中抗抑郁药处方模式的全国性前瞻性研究。

A nationwide prospective study on prescribing pattern of antidepressant drugs in Italian primary care.

机构信息

Department of Clinical and Experimental Medicine and Pharmacology, University of Messina, Via Consolare Valeria Gazzi, 98125 Messina, Italy.

出版信息

Eur J Clin Pharmacol. 2013 Feb;69(2):227-36. doi: 10.1007/s00228-012-1319-1. Epub 2012 Jun 17.

Abstract

PURPOSE

Our purpose was to explore antidepressant drug (AD) prescribing patterns in Italian primary care.

METHODS

Overall, 276 Italian general practitioners (GPs) participated in this prospective study, recruiting patients >18 years who started AD therapy during the enrolment period (January 2007 to June 2008). During visits at baseline and 3, 6, and 12 months, data about patients' characteristics and AD treatments were collected by the GPs. Discontinuation rate among new users of AD classes [i.e., selective serotonin reuptake inhibitors (SSRI); tricyclics (TCAs); other ADs) were compared. Logistic regression analyses were performed to identify predictors of AD discontinuation.

RESULTS

SSRIs were the most frequently prescribed ADs (N = 1,037; 75.3 %), especially paroxetine and escitalopram. SSRIs were more likely to be prescribed because of depressive disorders (80 %), and by GPs (51.1 %) rather than psychiatrists (31.8 %). Overall, 27.5 % (N = 378) of AD users discontinued therapy during the first year, mostly in the first 3 months (N = 242; 17.6 %), whereas 185 (13.4 %) were lost to follow-up. SSRI users showed the highest discontinuation rate (29 %). In patients with depressive disorders, younger age, psychiatrist-based diagnosis, and treatment started by GPs were independent predictors of SSRI discontinuation.

CONCLUSIONS

In Italy, ADs-especially SSRIs-are widely prescribed by GPs because of depressive/anxiety disorders. Active monitoring of AD users in general practice might reduce the AD discontinuation rate.

摘要

目的

本研究旨在探讨意大利初级保健中抗抑郁药(AD)的处方模式。

方法

共有 276 名意大利全科医生(GP)参与了这项前瞻性研究,他们招募了在入组期间(2007 年 1 月至 2008 年 6 月)开始 AD 治疗的>18 岁患者。在基线和 3、6、12 个月时,GP 收集患者特征和 AD 治疗的数据。比较新使用 AD 类药物(即选择性 5-羟色胺再摄取抑制剂(SSRIs);三环类抗抑郁药(TCAs);其他 AD)的停药率。采用逻辑回归分析识别 AD 停药的预测因素。

结果

SSRIs 是最常被处方的 AD(N=1037;75.3%),尤其是帕罗西汀和依西酞普兰。SSRIs 更有可能因抑郁障碍(80%)和 GP(51.1%)而不是精神科医生(31.8%)而被处方。总体而言,在第一年,378 名(27.5%)AD 使用者中断了治疗,其中大部分在最初的 3 个月(N=242;17.6%),而 185 名(13.4%)失访。SSRIs 使用者的停药率最高(29%)。在患有抑郁障碍的患者中,年龄较小、基于精神科医生的诊断以及 GP 开始治疗是 SSRIs 停药的独立预测因素。

结论

在意大利,AD-尤其是 SSRIs-被 GP 广泛用于治疗抑郁/焦虑障碍。在一般实践中对 AD 使用者进行积极监测可能会降低 AD 停药率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验